Related Experiment Video

Updated: Feb 15, 2026

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
06:44

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells

Published on: March 1, 2024

1.8K

Rationale for Ras and raf-kinase as a target for cancer therapeutics

Michelle Nottage1, Lillian L Siu

  • 1Princess Margaret Hospital, University Health Network, Department of Medical Oncology and Hematology, 610 University Avenue, Toronto, M5G 2M9, Ontario, Canada.

Current Pharmaceutical Design
|October 9, 2002
PubMed

Insights

This review explores RAS-mediated signal transduction, focusing on the RAS-RAF-MEK-ERK pathway. It discusses therapeutic strategies targeting these cancer cell aberrations for improved treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Cancer cells exhibit intrinsic aberrancies targeted by novel therapeutics.
  • RAS-mediated signal transduction is a key area of research in cancer.
  • Understanding these pathways is crucial for developing effective cancer treatments.

Purpose of the Study:

  • To review the RAS-RAF-MEK-ERK signaling pathway and its role in cancer.
  • To discuss other RAS activation consequences, including RHO-family proteins and PI3-kinase.
  • To explore pharmacological strategies for intervening in RAS-signaling pathways.

Main Methods:

  • Literature review of RAS-mediated signal transduction.
  • Analysis of the RAS-RAF-MEK-ERK pathway.
  • Discussion of various therapeutic interventions.

Main Results:

  • RAS activation influences cell growth, differentiation, cycling, and survival.
  • The RAS-RAF-MEK-ERK pathway is a central signaling cascade.
  • Multiple RAS-mediated signals are intricately balanced.

Conclusions:

  • Targeting RAS-signaling proteins offers rational therapeutic solutions for cancer.
  • Novel therapeutics are being developed based on understanding cancer cell aberrations.
  • Intervention strategies include small molecule inhibitors, antisense technology, and vaccine therapy.

More Related Videos

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

3.4K
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.5K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

No description available
4.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.5K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.5K